Dallas, TX -- (SBWire) -- 11/23/2010 -- SandlerResearch announce Men's Health Therapeutics Market to 2016 - Selective Serotonin Reuptake Inhibitors, Hormone Replacement Therapy and Phosphodiesterase Type-5 Inhibitors Will Dominate the Market
GBI Research has released its pharmaceutical industry research “Men's Health Therapeutics Market to 2016 - Selective Serotonin Reuptake Inhibitors, Hormone Replacement Therapy and Phosphodiesterase Type-5 Inhibitors will Dominate the Market”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global men’s health market. The report analyzes the markets for men’s health in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Furthermore, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
GBI Research finds that the men’s health market will continue to grow moderately. The prime reason for stagnancy will be the patent expiry of a top selling blockbuster, Viagra. The overall men’s health market is driven by the launch of late-stage pipeline candidates and the steady increase in prevalence and prescription population. The erectile dysfunction market controls a major portion of the men’s health market. In 2009 it accounted for 81% of the total men’s health market. Male hypogonadism accounts for 18% of the total market size. The premature ejaculation market represents a small portion of the total men’s health market. The premature ejaculation market has the highest level of unmet needs because it does not have any FDA approved products. However, it will grow at a higher rate during the forecast period compared to the erectile dysfunction and male hypogonadism market. This is because the premature ejaculation market will see the launch of new drugs in the near future. In 2009, the global men’s health market was estimated at $4,019m.
Scope
Annualized market data for the men’s health market from 2001 to 2009, forecast forward to 2016.
Analysis of the leading therapeutic segments, including erectile dysfunction, male hypogonadism and premature ejaculation.
Analysis of the men’s health market in the leading geographies of the world, which include the US (United States), the UK (United Kingdom), Germany, France, Italy, Spain and Japan.
Market characterization of the men’s health market, including market size, annual cost of therapy, sales volume and treatment usage patterns.
Key drivers and barriers that have a significant impact on the market.
Coverage of pipeline molecules in various phases of drug development.
Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline Inc., Abbott Laboratories, Endo-Pharmaceuticals Holding Inc., Janssen-Cilag EMEA, VIVUS Inc., Auxilium Pharmaceuticals, Inc., APP Pharmaceuticals, Inc, Columbia Laboratories, Inc., Watson Pharmaceuticals, Inc. and Valeant Pharmaceuticals International.
Key M&A activities, licensing agreements, that have taken place in 2009 in the global men’s health market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with more efficiency and better safety.
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 9
2 Global Men’s Health Therapeutics Market: Scope of Research 11
2.1 Overview 11
2.2 GBI Research Report Guidance 11
ABBREVIATIONS
Browse all : Pharmaceuticals Market
http://www.sandlerresearch.org/market-research/pharmaceuticals/
Browse all : GBI Research
http://www.sandlerresearch.org/publishers/gbi-research/
Browse all : Newly Published Market Research
http://www.sandlerresearch.org/LatestReport.aspx
Related Reports :
Hormone Replacement Therapy For Menopausal Symptoms Market Forecast
http://www.sandlerresearch.org/Reports/34592-hormone-replacement-therapy-for-menopausal-symptoms-market-foreca.html
Commercial Insight: Antidiabetics - DPP-IV inhibitors poised to sweep the market
http://www.sandlerresearch.org/Reports/7874-commercial-insight-antidiabetics-dpp-iv-inhibitors-poised-to-s.html
Pipeline and Commercial Insight: Testosterone Replacement Therapy - Topical formulations drive market growth
http://www.sandlerresearch.org/Reports/34586-pipeline-and-commercial-insight-testosterone-replacement-therapy.html
Testosterone Replacement Therapy Market Forecast
http://www.sandlerresearch.org/Reports/34591-testosterone-replacement-therapy-market-forecast.html
Dominating the cloud computing market: analysis of a market poll
http://www.sandlerresearch.org/Reports/6860-dominating-the-cloud-computing-market-analysis-of-a-market-poll.html
About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/
Original Source : Men Health Therapeutics Market
http://www.sandlerresearch.org/reports/33052-mens-health-therapeutics-market-to-2016-selective-serotonin-re.html
Buy Now : Market Research
http://www.sandlerresearch.org/reports/15763-major-depressive-disorder-mdd-drug-pipeline-analysis-and-mark.html
Browse complete Report at : Men's Health Therapeutics Market to 2016 - Selective Serotonin Reuptake Inhibitors, Hormone Replacement Therapy and Phosphodiesterase Type-5 Inhibitors Will Dominate the Market
http://www.sandlerresearch.org/reports/33052-mens-health-therapeutics-market-to-2016-selective-serotonin-re.html
Men's Health Therapeutics Market to 2016 - Now Available at SandlerResearch
GBI Research has released its pharmaceutical industry research “Men's Health Therapeutics Market to 2016 - Selective Serotonin Reuptake Inhibitors, Hormone Replacement Therapy and Phosphodiesterase Type-5 Inhibitors will Dominate the Market